W81XWH11C0078
Definitive Contract
Overview
Government Description
SBIR PHASE I (O103-H05-3066)
Awardee
Awarding Agency
Place of Performance
Cleveland, OH 44118 United States
Pricing
Fixed Price
Set Aside
Small Business Set Aside - Total (SBA)
Extent Competed
Full And Open Competition After Exclusion Of Sources
Est. Average FTE
3
Related Opportunity
Analysis Notes
Amendment Since initial award the Potential End Date has been extended from 10/14/11 to 03/29/19.
Neurowave Systems was awarded
Definitive Contract W81XWH11C0078 (W81XWH-11-C-0078)
for Sbir Phase I (O103-H05-3066)
worth up to $3,948,078
by Army Medical Research and Development Command
in March 2011.
The contract
has a duration of 8 years and
was awarded
through solicitation Deployable Closed-Look Anesthesia System
with a Small Business Total set aside
with
NAICS 541712 and
PSC AN91
via direct negotiation acquisition procedures with 65 bids received.
SBIR Details
Research Type
Small Business Innovation Research Program (SBIR) Phase I
Title
Deployable Closed-Loop Anesthesia System
Abstract
The AutoTIVA system, to be developed under this program, comes as an answer to the Army requirement for a "deployable automated analgesia and anesthesia system".The AutoTIVA device concept is akin to that of an autopilot for anesthesia and sedation, where the administration of both intravenous analgesics and hypnotics are adjusted continuously in real-time, to drive and maintain patients in a pre-defined cortical activity level.This system integrates a clinical-grade 2-channel electroencephalographic device to acquire the patient brainwaves, and our proprietary WAVcns analysis to calculate the level of cortical activity from the acquired signals. The proprietary WAVcns index is used as a feedback quantity to regulate the infusion rates of both analgesics and hypnotics. Drug delivery is ensured via two off-the-shelf syringe infusion pumps directly connected to the AutoTIVA platform.The proposed Phase II program builds on our Phase I results, transitioning from a prototype-level system to a first commercial device deployable at the outset of the program. In addition, further enhancements of the system user interface and control mechanism will be made to address some of the limitations identified in the Phase I, and based on the feedback from our Clinical Advisory Board.
Research Objective
The goal of phase I is to establish the technical merit, feasibility, and commercial potential of proposed R&D efforts and determine the quality of performance of the small business awardee organization.
Topic Code
OSD10-H05
Agency Tracking Number
O2-1239
Solicitation Number
2010.3
Contact
Tatjana Zikov
Status
(Complete)
Last Modified 7/2/18
Period of Performance
3/15/11
Start Date
3/29/19
Current End Date
3/29/19
Potential End Date
Obligations
$3.9M
Total Obligated
$3.9M
Current Award
$3.9M
Potential Award
Award Hierarchy
Definitive Contract
W81XWH11C0078
Subcontracts
Activity Timeline
Subcontract Awards
Disclosed subcontracts for W81XWH11C0078
Opportunity Lifecycle
Procurement history for W81XWH11C0078
Transaction History
Modifications to W81XWH11C0078
People
Suggested agency contacts for W81XWH11C0078
Competition
Number of Bidders
65
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Performance Based Acquisition
Yes
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Defense Program
None
DoD Claimant Code
Services
IT Commercial Item Category
Not Applicable
Awardee UEI
J8LLPBAEMJG3
Awardee CAGE
4D5M1
Agency Detail
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
W23RYX
Created By
teely.e.shaffer.civ@mail.mil
Last Modified By
teely.e.shaffer.civ@mail.mil
Approved By
teely.e.shaffer.civ@mail.mil
Legislative
Legislative Mandates
None Applicable
Performance District
OH-11
Senators
Sherrod Brown
J.D. (James) Vance
J.D. (James) Vance
Representative
Shontel Brown
Modified: 7/2/18